WebMar 5, 2014 · Whether doxorubicin alone or the combination of doxorubicin and ifosfamide should be used routinely is still controversial. We assessed whether dose intensification … WebJun 7, 2024 · Synovial sarcoma is a rare malignant tumor that generally requires a multidisciplinary therapeutic approach. In this study we report the experience of a single surgeon, evaluating surgical and oncological outcomes of the cases he treated through his 30 years carrier. Methods We enrolled patients treated surgically between 1988 and 2024.
Did you know?
WebJ Clin Oncol 11: 1269–1275, 1993. PubMed CAS Google Scholar Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma … WebJ Clin Oncol 1993, 11 :1269–1275. PubMed CAS Google Scholar Baker LH, Frank J, Fine G, et al.: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and …
WebApr 20, 2024 · J Clin Oncol. 1993;11:1276–1285. 4. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta … WebNov 15, 2024 · J Clin Oncol. 1993; 11(7): 1276–1285. pmid:8315425 . View Article ... and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993; 11(7): 1269–1275. pmid:8315424 . View Article PubMed/NCBI Google Scholar 14. Stacchiotti S, Dagrada GP, Sanfilippo R, Negri T, Vittimberga I, Ferrari S, et al. Anthracycline-based chemotherapy in ...
WebNov 1, 2004 · The unadjusted hazard ratio for the effect of NAC on disease-specific survival was 0.75 (95% CI: 0.45–1.2). Using the Cox proportional hazards model stratified by … WebJ Clin Oncol. 1993;11(7):1269–1275. 41. Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.
WebNov 7, 1993 · DOI: 10.1200/JCO.1993.11.7.1276. Abstract. Purpose and methods: Doxorubicin alone or with dacarbazine (DTIC; AD) is considered the best available therapy …
WebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar: 7. Antman K, Crowley J, Balcerzak SP, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 11: 1276-1285, 1993 Link, Google Scholar: 8. how to calculate hra from gross salaryWebOct 10, 2006 · Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR (1993) ... J Clin Oncol 11: 1269–1275. CAS Article Google Scholar Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D ... mgccc andrews hallWebGoogle Scholar. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or … mgccc augusoft netWebMost cited. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L) mgccc athletic directorWebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar 7. Antman K , Crowley J , Balcerzak SP , et al: An intergroup phase III randomized study of doxorubicin and … how to calculate hrdf levyWebMar 1, 2005 · J Clin Oncol 1993; 11: 1269 – 1275. Edmonson JH Ryan LM Blum RH . Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or … mgcc cape townWebAt Levine Cancer Institute, your well-being is always our top priority. From extensive cleaning protocols to coronavirus screenings for staff and patients, we’re doing everything we can … how to calculate hra in tax